Logo image of BLDR

BUILDERS FIRSTSOURCE INC (BLDR) Stock Fundamental Analysis

USA - NYSE:BLDR - US12008R1077 - Common Stock

119.61 USD
+1.41 (+1.19%)
Last: 9/29/2025, 4:50:12 PM
119.6 USD
-0.01 (-0.01%)
After Hours: 9/29/2025, 4:50:12 PM
Fundamental Rating

4

BLDR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 41 industry peers in the Building Products industry. There are concerns on the financial health of BLDR while its profitability can be described as average. BLDR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BLDR had positive earnings in the past year.
In the past year BLDR had a positive cash flow from operations.
Each year in the past 5 years BLDR has been profitable.
In the past 5 years BLDR always reported a positive cash flow from operatings.
BLDR Yearly Net Income VS EBIT VS OCF VS FCFBLDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

The Return On Assets of BLDR (6.60%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 18.10%, BLDR is in the better half of the industry, outperforming 68.29% of the companies in the same industry.
BLDR has a Return On Invested Capital of 9.90%. This is comparable to the rest of the industry: BLDR outperforms 56.10% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BLDR is significantly above the industry average of 12.76%.
The 3 year average ROIC (22.36%) for BLDR is well above the current ROIC(9.90%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 6.6%
ROE 18.1%
ROIC 9.9%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
BLDR Yearly ROA, ROE, ROICBLDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

With a Profit Margin value of 4.74%, BLDR is not doing good in the industry: 63.41% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of BLDR has grown nicely.
BLDR's Operating Margin of 7.70% is on the low side compared to the rest of the industry. BLDR is outperformed by 65.85% of its industry peers.
BLDR's Operating Margin has improved in the last couple of years.
BLDR has a Gross Margin of 31.58%. This is comparable to the rest of the industry: BLDR outperforms 48.78% of its industry peers.
In the last couple of years the Gross Margin of BLDR has grown nicely.
Industry RankSector Rank
OM 7.7%
PM (TTM) 4.74%
GM 31.58%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
BLDR Yearly Profit, Operating, Gross MarginsBLDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BLDR is creating value.
Compared to 1 year ago, BLDR has less shares outstanding
Compared to 5 years ago, BLDR has less shares outstanding
The debt/assets ratio for BLDR is higher compared to a year ago.
BLDR Yearly Shares OutstandingBLDR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
BLDR Yearly Total Debt VS Total AssetsBLDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

The Debt to FCF ratio of BLDR is 3.93, which is a good value as it means it would take BLDR, 3.93 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 3.93, BLDR perfoms like the industry average, outperforming 51.22% of the companies in the same industry.
BLDR has a Debt/Equity ratio of 1.12. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of BLDR (1.12) is worse than 82.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 3.93
Altman-Z N/A
ROIC/WACC0.97
WACC10.22%
BLDR Yearly LT Debt VS Equity VS FCFBLDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.79 indicates that BLDR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.79, BLDR is in line with its industry, outperforming 41.46% of the companies in the same industry.
A Quick Ratio of 1.08 indicates that BLDR should not have too much problems paying its short term obligations.
BLDR has a Quick ratio of 1.08. This is in the lower half of the industry: BLDR underperforms 63.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.08
BLDR Yearly Current Assets VS Current LiabilitesBLDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

BLDR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.50%.
Measured over the past years, BLDR shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.71% on average per year.
Looking at the last year, BLDR shows a decrease in Revenue. The Revenue has decreased by -6.39% in the last year.
BLDR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.64% yearly.
EPS 1Y (TTM)-33.5%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-32%
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-4.99%

3.2 Future

BLDR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -7.26% yearly.
Based on estimates for the next years, BLDR will show a small growth in Revenue. The Revenue will grow by 0.03% on average per year.
EPS Next Y-39.57%
EPS Next 2Y-20%
EPS Next 3Y-7.26%
EPS Next 5YN/A
Revenue Next Year-7%
Revenue Next 2Y-2.59%
Revenue Next 3Y0.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLDR Yearly Revenue VS EstimatesBLDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
BLDR Yearly EPS VS EstimatesBLDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.90, which indicates a correct valuation of BLDR.
BLDR's Price/Earnings ratio is rather cheap when compared to the industry. BLDR is cheaper than 87.80% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.54. BLDR is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 16.21, BLDR is valued correctly.
Based on the Price/Forward Earnings ratio, BLDR is valued a bit cheaper than the industry average as 60.98% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BLDR to the average of the S&P500 Index (23.05), we can say BLDR is valued slightly cheaper.
Industry RankSector Rank
PE 12.9
Fwd PE 16.21
BLDR Price Earnings VS Forward Price EarningsBLDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLDR is valued a bit cheaper than 73.17% of the companies in the same industry.
92.68% of the companies in the same industry are more expensive than BLDR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.12
EV/EBITDA 9.82
BLDR Per share dataBLDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

BLDR has a very decent profitability rating, which may justify a higher PE ratio.
BLDR's earnings are expected to decrease with -7.26% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y-20%
EPS Next 3Y-7.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BLDR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BUILDERS FIRSTSOURCE INC

NYSE:BLDR (9/29/2025, 4:50:12 PM)

After market: 119.6 -0.01 (-0.01%)

119.61

+1.41 (+1.19%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners100.23%
Inst Owner Change-1.46%
Ins Owners2.49%
Ins Owner Change4.19%
Market Cap13.22B
Analysts77.04
Price Target142.66 (19.27%)
Short Float %6.61%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.42%
Min EPS beat(2)2.38%
Max EPS beat(2)12.47%
EPS beat(4)4
Avg EPS beat(4)6.07%
Min EPS beat(4)1.07%
Max EPS beat(4)12.47%
EPS beat(8)8
Avg EPS beat(8)12.44%
EPS beat(12)12
Avg EPS beat(12)27.52%
EPS beat(16)16
Avg EPS beat(16)42.11%
Revenue beat(2)0
Avg Revenue beat(2)-2.44%
Min Revenue beat(2)-2.96%
Max Revenue beat(2)-1.92%
Revenue beat(4)0
Avg Revenue beat(4)-7.3%
Min Revenue beat(4)-17.56%
Max Revenue beat(4)-1.92%
Revenue beat(8)1
Avg Revenue beat(8)-4.98%
Revenue beat(12)5
Avg Revenue beat(12)-1.63%
Revenue beat(16)9
Avg Revenue beat(16)2.64%
PT rev (1m)0.42%
PT rev (3m)-1.53%
EPS NQ rev (1m)-5.73%
EPS NQ rev (3m)-31.44%
EPS NY rev (1m)-1%
EPS NY rev (3m)-15.47%
Revenue NQ rev (1m)-0.73%
Revenue NQ rev (3m)-11.97%
Revenue NY rev (1m)-0.41%
Revenue NY rev (3m)-6.35%
Valuation
Industry RankSector Rank
PE 12.9
Fwd PE 16.21
P/S 0.83
P/FCF 11.12
P/OCF 8.39
P/B 3.16
P/tB N/A
EV/EBITDA 9.82
EPS(TTM)9.27
EY7.75%
EPS(NY)7.38
Fwd EY6.17%
FCF(TTM)10.75
FCFY8.99%
OCF(TTM)14.26
OCFY11.92%
SpS144.23
BVpS37.79
TBVpS-9.71
PEG (NY)N/A
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 6.6%
ROE 18.1%
ROCE 12.75%
ROIC 9.9%
ROICexc 9.99%
ROICexgc 22.22%
OM 7.7%
PM (TTM) 4.74%
GM 31.58%
FCFM 7.46%
ROA(3y)16.93%
ROA(5y)14.89%
ROE(3y)37.68%
ROE(5y)35.24%
ROIC(3y)22.36%
ROIC(5y)20.5%
ROICexc(3y)22.6%
ROICexc(5y)21.09%
ROICexgc(3y)52.47%
ROICexgc(5y)46.44%
ROCE(3y)28.8%
ROCE(5y)26.39%
ROICexcg growth 3Y-14.33%
ROICexcg growth 5Y9.79%
ROICexc growth 3Y-13.16%
ROICexc growth 5Y2.57%
OM growth 3Y-6.99%
OM growth 5Y12.55%
PM growth 3Y-8.82%
PM growth 5Y16.6%
GM growth 3Y3.73%
GM growth 5Y3.86%
F-Score4
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 3.93
Debt/EBITDA 2.6
Cap/Depr 67.97%
Cap/Sales 2.43%
Interest Coverage 5.27
Cash Conversion 87.67%
Profit Quality 157.18%
Current Ratio 1.79
Quick Ratio 1.08
Altman-Z N/A
F-Score4
WACC10.22%
ROIC/WACC0.97
Cap/Depr(3y)73.83%
Cap/Depr(5y)71.85%
Cap/Sales(3y)2.2%
Cap/Sales(5y)1.81%
Profit Quality(3y)125.27%
Profit Quality(5y)102.16%
High Growth Momentum
Growth
EPS 1Y (TTM)-33.5%
EPS 3Y4.76%
EPS 5Y40.71%
EPS Q2Q%-32%
EPS Next Y-39.57%
EPS Next 2Y-20%
EPS Next 3Y-7.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.39%
Revenue growth 3Y-6.23%
Revenue growth 5Y17.64%
Sales Q2Q%-4.99%
Revenue Next Year-7%
Revenue Next 2Y-2.59%
Revenue Next 3Y0.03%
Revenue Next 5YN/A
EBIT growth 1Y-38.45%
EBIT growth 3Y-12.79%
EBIT growth 5Y32.41%
EBIT Next Year0.24%
EBIT Next 3Y5.03%
EBIT Next 5YN/A
FCF growth 1Y-61.23%
FCF growth 3Y-0.52%
FCF growth 5Y30.71%
OCF growth 1Y-55.18%
OCF growth 3Y2.41%
OCF growth 5Y30.02%